Detalles de la búsqueda
1.
The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study.
Eur Urol Open Sci
; 62: 8-15, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38585206
2.
Of mice and men--warning: intact versus castrated adult male mice as xenograft hosts are equivalent to hypogonadal versus abiraterone treated aging human males, respectively.
Prostate
; 73(12): 1316-25, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23775398
3.
How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come.
Eur Urol
; 82(6): 578-580, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36167598
4.
A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging-directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men.
Eur Urol
; 82(3): 318-326, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35341658
5.
Yield of Repeat Targeted Direct in-Bore Magnetic Resonance-Guided Prostate Biopsy (MRGB) of the Same Lesions in Men Having a Prior Negative Targeted MRGB.
Korean J Radiol
; 19(4): 733-741, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29962879
Resultados
1 -
5
de 5
1
Próxima >
>>